noscript

News and Announcements

SUDA Presents Data On Novel Penetration-Enhancing Technology

  • Published November 17, 2016 3:23PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

17th November 2016

SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, today announced that Mr. Stephen Carter, Managing Director and CEO, presented data on the Company’s novel penetration-enhancing technology at the Annual Symposium of Drug Delivery Systems, being held on 16-19 November 2016 in Nanjing, China.

This scientific conference brings together scientists, academia, healthcare providers, policy makers and investors to provide insights into advances in drug delivery technologies. Mr. Carter chaired a session on “Tackling the Barriers in Different Routes of Drug Delivery.”

SUDA recently filed a provisional patent application with IP Australia for its novel mucosal penetration drug delivery technology. Mr. Carter presented data suggesting that the Company’s new technology, based on unique combinations of hydrotropes, can significantly enhance the permeation of active drugs through the oro-mucosal membrane into the blood system.

If you would like to download the full announcement, please click on the link below. 

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now